CRISPR Therapeutics (CRSP) Is Down 7.1% After Slower Casgevy Rollout and Wider 2025 Net Loss – What's Changed [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
thalassemia has been slower than hoped, contributing to a 2025 net loss of about US$581.60 million despite holding roughly US$2.00 billions in cash and marketable securities. At the same time, analysts' projections for substantial revenue growth from Casgevy and improved earnings estimates have fueled fresh attention on how CRISPR Therapeutics' strong balance sheet might support this expansion phase. We'll now examine how expectations for Casgevy's revenue trajectory shape CRISPR Therapeutics' investment narrative despite recent share price weakness. This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality What Is CRISPR Therapeutics' Investment Narrative? To own CRISPR Therapeutics today, you have to believe Casgevy can eventually justify years of heavy investment and that the company can translate its broader gene-editing pipeline into a real business, not just a science project. The latest update, showing a slow Casg
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Forget CRISPR Therapeutics: This Gene-Editing Player Already Boasts the Profits It Dreams Of [Yahoo! Finance]Yahoo! Finance
- Is CRISPR Therapeutics Stock Too Risky to Buy Right Now? [Yahoo! Finance]Yahoo! Finance
- Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought [Yahoo! Finance]Yahoo! Finance
- Here's What Analysts Are Saying About CRISPR Therapeutics AG (CRSP) [Yahoo! Finance]Yahoo! Finance
- Assessing CRISPR Therapeutics (CRSP) Valuation After FDA Draft Guidance And Recent Weak Earnings [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 2/20/26 - Form 4
- 2/20/26 - Form 4
- 2/17/26 - Form SCHEDULE
- CRSP's page on the SEC website